These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20785280)

  • 1. Regulation 33B in Practice.
    Br Med J; 1944 Feb; 1(4336):223-4. PubMed ID: 20785280
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer.
    Yin H; Song P; Su R; Yang G; Dong L; Luo M; Wang B; Gong B; Liu C; Song W; Wang F; Ma Y; Zhang J; Wang W; Yu J
    Sci Rep; 2016 Jan; 6():18824. PubMed ID: 26729612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MicroRNA-33b inhibits cell proliferation in hepatocellular carcinoma via targeting SALL4].
    Li Y; Li R; Fu X; Zhou W; Peng S; Fu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):905-10. PubMed ID: 27640788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of miR-33b in glioma and its regulatory role in tumor cell proliferation, invasion and migration.
    Qi Y; Gao Y
    Biomark Med; 2020 May; 14(7):539-548. PubMed ID: 32462908
    [No Abstract]   [Full Text] [Related]  

  • 5. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC.
    Xu G; Wei X; Tu Q; Zhou C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31799620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-33b Inhibits the Proliferation and Migration of Osteosarcoma Cells via Targeting Hypoxia-Inducible Factor-1α.
    Zhou Y; Yang C; Wang K; Liu X; Liu Q
    Oncol Res; 2017 Mar; 25(3):397-405. PubMed ID: 27662380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma.
    Li F; Hao M; Feng X; Zang M; Qin Y; Yi S; Li Z; Xu Y; Zhou L; Sui W; Deng S; Zou D; Zhan F; Qiu L
    Leuk Res; 2015 Jul; 39(7):793-9. PubMed ID: 25975752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling.
    Qu J; Li M; An J; Zhao B; Zhong W; Gu Q; Cao L; Yang H; Hu C
    Int J Oncol; 2015 Dec; 47(6):2141-52. PubMed ID: 26459797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-33b regulates sensitivity to daunorubicin in acute myelocytic leukemia by regulating eukaryotic translation initiation factor 5A-2.
    Liu Y; Lei P; Qiao H; Sun K; Lu X; Bao F; Yu R; Lian C; Li Y; Chen W; Xue F
    J Cell Biochem; 2020 Jan; 121(1):385-393. PubMed ID: 31222822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth.
    Zhai S; Zhao L; Lin T; Wang W
    J Cell Biochem; 2019 Apr; 120(4):6651-6660. PubMed ID: 30368888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
    Zheng XM; Xu CW; Wang F
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.
    Lin Y; Liu AY; Fan C; Zheng H; Li Y; Zhang C; Wu S; Yu D; Huang Z; Liu F; Luo Q; Yang CJ; Ouyang G
    Sci Rep; 2015 Apr; 5():9995. PubMed ID: 25919570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression.
    Yang X; Zhao Q; Yin H; Lei X; Gan R
    J Drug Target; 2017 Aug; 25(7):653-660. PubMed ID: 28436711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of IRAK3 by miR-33b-3p relieves chondrocyte inflammation and apoptosis in an in vitro osteoarthritis model.
    Tao T; Zhang Y; Wei H; Heng K
    Biosci Biotechnol Biochem; 2021 Feb; 85(3):545-552. PubMed ID: 33590831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21
    Xu S; Huang H; Chen YN; Deng YT; Zhang B; Xiong XD; Yuan Y; Zhu Y; Huang H; Xie L; Liu X
    Cell Cycle; 2016 Nov; 15(21):2920-2930. PubMed ID: 27559850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation.
    Price NL; Holtrup B; Kwei SL; Wabitsch M; Rodeheffer M; Bianchini L; Suárez Y; Fernández-Hernando C
    Mol Cell Biol; 2016 Feb; 36(7):1180-93. PubMed ID: 26830228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.
    Zhang P; Huang C; Fu C; Tian Y; Hu Y; Wang B; Strasner A; Song Y; Song E
    Oncotarget; 2015; 6(12):9834-53. PubMed ID: 25868853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SREBF1/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo.
    Nishino T; Horie T; Baba O; Sowa N; Hanada R; Kuwabara Y; Nakao T; Nishiga M; Nishi H; Nakashima Y; Nakazeki F; Ide Y; Koyama S; Kimura M; Nagata M; Yoshida K; Takagi Y; Nakamura T; Hasegawa K; Miyamoto S; Kimura T; Ono K
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2460-2473. PubMed ID: 30354203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.
    Liao W; Gu C; Huang A; Yao J; Sun R
    Clin Transl Oncol; 2016 May; 18(5):449-56. PubMed ID: 26329295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Differential Roles of MicroRNA-33a and -33b During Atherosclerosis Progression With Genetically Modified Mice.
    Koyama S; Horie T; Nishino T; Baba O; Sowa N; Miyasaka Y; Kuwabara Y; Nakao T; Nishiga M; Nishi H; Nakashima Y; Nakazeki F; Ide Y; Kimura M; Tsuji S; Ruiz Rodriguez R; Xu S; Yamasaki T; Otani C; Watanabe T; Nakamura T; Hasegawa K; Kimura T; Ono K
    J Am Heart Assoc; 2019 Jul; 8(13):e012609. PubMed ID: 31242815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.